PT2579852E - Composição farmacêutica para pulverização compreendendo um análogo da vitamina d e corticosteroide - Google Patents

Composição farmacêutica para pulverização compreendendo um análogo da vitamina d e corticosteroide Download PDF

Info

Publication number
PT2579852E
PT2579852E PT117260554T PT11726055T PT2579852E PT 2579852 E PT2579852 E PT 2579852E PT 117260554 T PT117260554 T PT 117260554T PT 11726055 T PT11726055 T PT 11726055T PT 2579852 E PT2579852 E PT 2579852E
Authority
PT
Portugal
Prior art keywords
corticosteroid
analogue
vitamin
spray composition
pharmaceutical spray
Prior art date
Application number
PT117260554T
Other languages
English (en)
Inventor
Marianne Lind
Gritt Rasmussen
Mette Rydahl Sonne
Jens Hansen
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44475023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2579852(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of PT2579852E publication Critical patent/PT2579852E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/16—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means
    • B65D83/20—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant characterised by the actuating means operated by manual action, e.g. button-type actuator or actuator caps
    • B65D83/207—Actuators comprising a manually operated valve and being attachable to the aerosol container, e.g. downstream a valve fitted to the container; Actuators associated to container valves with valve seats located outside the aerosol container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT117260554T 2010-06-11 2011-06-10 Composição farmacêutica para pulverização compreendendo um análogo da vitamina d e corticosteroide PT2579852E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35389310P 2010-06-11 2010-06-11

Publications (1)

Publication Number Publication Date
PT2579852E true PT2579852E (pt) 2015-02-24

Family

ID=44475023

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117260554T PT2579852E (pt) 2010-06-11 2011-06-10 Composição farmacêutica para pulverização compreendendo um análogo da vitamina d e corticosteroide

Country Status (26)

Country Link
US (11) US9119781B2 (pt)
EP (2) EP2859886A1 (pt)
JP (3) JP5945268B2 (pt)
KR (2) KR101619077B1 (pt)
CN (1) CN102939078B (pt)
AU (1) AU2011264198B2 (pt)
BR (1) BR112012030653B1 (pt)
CA (1) CA2800181C (pt)
CY (1) CY1115991T1 (pt)
DK (1) DK2579852T3 (pt)
ES (1) ES2529506T3 (pt)
HK (1) HK1182321A1 (pt)
HR (1) HRP20150154T1 (pt)
IL (2) IL222865A (pt)
MX (1) MX2012013591A (pt)
MY (1) MY167691A (pt)
NZ (1) NZ603470A (pt)
PL (1) PL2579852T3 (pt)
PT (1) PT2579852E (pt)
RS (1) RS53809B1 (pt)
RU (1) RU2576607C2 (pt)
SG (1) SG185521A1 (pt)
SI (1) SI2579852T1 (pt)
UA (1) UA109785C2 (pt)
WO (1) WO2011154004A1 (pt)
ZA (1) ZA201208281B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
CN102939078B (zh) * 2010-06-11 2014-12-24 利奥制药有限公司 含有维生素d类似物和皮质类固醇的药用喷雾剂组合物
KR20150028840A (ko) * 2012-07-06 2015-03-16 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
AR096459A1 (es) * 2013-06-03 2015-12-30 Tolmar Inc Composiciones de corticosteroides y método de fabricación
WO2015174910A1 (en) * 2014-05-13 2015-11-19 Aerosol Scandinavia Ab Composition having improved spraying characteristics comprising vegetable oils and triglycerides and/or mineral oils
CN105708842B (zh) * 2014-12-03 2020-06-26 四川海思科制药有限公司 一种外用药物组合物
US9265727B1 (en) 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
CN104490782B (zh) * 2015-01-20 2017-04-12 北京康蒂尼药业有限公司 一种外用温控泡沫剂及其制备方法和用途
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
CN104800187B (zh) * 2015-04-22 2017-07-14 青岛正大海尔制药有限公司 一种阿法骨化醇软胶囊及其制备方法
KR101641372B1 (ko) * 2015-05-08 2016-07-20 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US20180028767A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Topical spray system of halobetasol
EP3515422A1 (en) 2016-09-21 2019-07-31 Avexxin AS Pharmaceutical composition
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
MX2021006375A (es) 2018-11-29 2021-08-11 Ethicon Inc Aplicador y metodo para revestimiento de sala de operaciones.
CN110302194B (zh) * 2019-07-23 2023-01-31 广州市皮肤病防治所(广州市性病防治监测中心) 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂
GB201914498D0 (en) * 2019-10-08 2019-11-20 Leo Pharma As An anhydrous pharmaceutical composition for maintenance treatment of psoriasis
US11518604B2 (en) * 2020-05-28 2022-12-06 Ethicon, Inc. Systems, methods and devices for aerosol spraying of silicone based topical skin adhesives for sealing wounds
US11718753B2 (en) 2020-05-28 2023-08-08 Ethicon, Inc. Topical skin closure compositions and systems
US11589867B2 (en) 2020-05-28 2023-02-28 Ethicon, Inc. Anisotropic wound closure systems
US11479669B2 (en) 2020-05-28 2022-10-25 Ethicon, Inc. Topical skin closure compositions and systems
US11712229B2 (en) 2020-05-28 2023-08-01 Ethicon, Inc. Systems, devices and methods for dispensing and curing silicone based topical skin adhesives
CN111904679A (zh) * 2020-07-31 2020-11-10 李光娟 一种皮肤科脓疮护理装置
US20230414537A1 (en) * 2022-06-21 2023-12-28 Taro Pharmaceutical Industries Ltd. Topical naftifine compositions

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3722753A (en) * 1966-12-01 1973-03-27 Colgate Palmolive Co Dispensing attachment for pressurized containers
US4087026A (en) 1971-09-15 1978-05-02 Petterson Tor H Barrier package
US4411883A (en) * 1973-02-05 1983-10-25 Colgate-Palmolive Company Antiperspirant
US4122978A (en) 1975-06-18 1978-10-31 The Gillette Company Pressurized package for dispensing a product in a finely dispersed spray pattern with little dilution by propellant
JP2772073B2 (ja) 1989-11-14 1998-07-02 東洋エアゾール工業株式会社 粉末エアゾール組成物
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5098694A (en) * 1990-09-25 1992-03-24 The Procter & Gamble Company Natural deodorant compositions
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
ES2123821T3 (es) 1993-08-10 1999-01-16 Boots Co Plc Formulacion de pulverizacion que tiene un efecto refrescante.
JP3881400B2 (ja) 1995-02-22 2007-02-14 久光製薬株式会社 エアゾール組成物及びエアゾール型外用製剤
US5635165A (en) * 1995-09-27 1997-06-03 Helene Curtis, Inc. Antiperspirant deodorant compositions
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JPH10182375A (ja) 1996-12-27 1998-07-07 Mirubon:Kk スプレー式酸性染毛料
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
JP2000063254A (ja) 1998-08-19 2000-02-29 Kanpehapio:Kk 皮膚保護クリーム
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
JP2000086500A (ja) 1998-09-18 2000-03-28 Toyo Aerosol Ind Co Ltd エアゾール型軟膏組成物
ES2671785T3 (es) * 1999-04-23 2018-06-08 Leo Pharma A/S Composición farmacéutica para uso dérmico para el tratamiento de la psoriasis que comprende vitamina D y un corticosteroide
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
AU9163701A (en) * 2000-10-27 2002-05-06 Leo Pharma As Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
JP2002138015A (ja) 2000-10-27 2002-05-14 Toyo Aerosol Ind Co Ltd スプレー組成物
JP2002241309A (ja) 2001-02-20 2002-08-28 Toyo Aerosol Ind Co Ltd 消炎剤組成物および消炎エアゾール製品
JP4450545B2 (ja) * 2001-07-05 2010-04-14 ロート製薬株式会社 エアゾール製剤
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
AU2003294027B2 (en) 2002-12-17 2009-09-10 Galderma S.A. Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
FR2852239B1 (fr) 2003-03-11 2006-08-11 Oreal Dispositif aerosol contenant une composition cosmetique comprenant un poluyrethane et un agent propulseur comprenant du dimethylether et au moins un hydrocarbure
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
AU2005253733A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
BRPI0511387A (pt) 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
FR2871698B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871700B1 (fr) 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
US7134579B2 (en) 2004-11-15 2006-11-14 Ultramotive Corporation RTV silicone spray system
WO2006111426A1 (en) 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
BRPI0612428A2 (pt) 2005-05-09 2010-11-09 Foamix Ltd composição farmacêutica higroscópica, veìculo farmacêutico espumoso e composição farmacêutica espumosa
ES2407407T3 (es) 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina
US7698878B2 (en) 2005-10-17 2010-04-20 Dispensing Patents International, Llc Aerosol container with integral mounting cup and anti-clog valve
JP2009519957A (ja) * 2005-12-14 2009-05-21 ザーズ， インコーポレイテッド 薬物の皮膚送達のためのスプレイ−オン処方物および方法
JP4909651B2 (ja) 2006-06-12 2012-04-04 株式会社ダイゾー 噴霧用エアゾール組成物
WO2008002646A2 (en) * 2006-06-27 2008-01-03 Schering-Plough Healthcare Products, Inc. Aerosol lotion formulations
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008152444A2 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2146780A1 (en) 2007-05-11 2010-01-27 Sonneborn Inc. Petrolatums having silicone-like properties
CA2711703A1 (en) * 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
JP2012505236A (ja) * 2008-10-10 2012-03-01 シェーリング コーポレイション コルチコステロイド組成物およびそれの治療方法
EP2335675B1 (de) 2009-12-10 2015-02-18 Neubourg Skin Care GmbH & Co. KG Emulgatorfreie, Polymer-stabilisierte Schaumformulierungen
CN102939078B (zh) * 2010-06-11 2014-12-24 利奥制药有限公司 含有维生素d类似物和皮质类固醇的药用喷雾剂组合物
KR20150028840A (ko) * 2012-07-06 2015-03-16 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물

Also Published As

Publication number Publication date
US10130640B2 (en) 2018-11-20
KR101619077B1 (ko) 2016-05-10
HK1182321A1 (en) 2013-11-29
JP6258402B2 (ja) 2018-01-10
JP2016188223A (ja) 2016-11-04
MX2012013591A (es) 2013-02-01
RS53809B1 (en) 2015-06-30
IL222865A (en) 2016-08-31
US20200009160A1 (en) 2020-01-09
MY167691A (en) 2018-09-21
EP2579852A1 (en) 2013-04-17
JP2018065850A (ja) 2018-04-26
US20190388439A1 (en) 2019-12-26
IL247260B (en) 2020-07-30
JP5945268B2 (ja) 2016-07-05
KR20130109096A (ko) 2013-10-07
HRP20150154T1 (hr) 2015-04-10
US20190381074A1 (en) 2019-12-19
DK2579852T3 (en) 2015-02-23
RU2576607C2 (ru) 2016-03-10
WO2011154004A1 (en) 2011-12-15
SI2579852T1 (sl) 2015-03-31
UA109785C2 (uk) 2015-10-12
EP2859886A1 (en) 2015-04-15
IL222865A0 (en) 2012-12-31
US10682364B2 (en) 2020-06-16
EP2579852B1 (en) 2014-12-31
US20190015430A1 (en) 2019-01-17
KR20160054614A (ko) 2016-05-16
US20230398131A1 (en) 2023-12-14
US10716799B2 (en) 2020-07-21
AU2011264198A1 (en) 2012-11-29
KR101749514B1 (ko) 2017-06-21
US10660908B2 (en) 2020-05-26
US20150313919A1 (en) 2015-11-05
US9119781B2 (en) 2015-09-01
BR112012030653B1 (pt) 2021-10-13
US20190381073A1 (en) 2019-12-19
ZA201208281B (en) 2014-01-29
CY1115991T1 (el) 2017-01-25
CA2800181C (en) 2016-03-15
CA2800181A1 (en) 2011-12-15
SG185521A1 (en) 2012-12-28
PL2579852T3 (pl) 2015-04-30
US9566286B2 (en) 2017-02-14
US20210128588A1 (en) 2021-05-06
ES2529506T3 (es) 2015-02-20
CN102939078B (zh) 2014-12-24
US20130123720A1 (en) 2013-05-16
AU2011264198B2 (en) 2015-04-09
NZ603470A (en) 2014-12-24
JP2013533859A (ja) 2013-08-29
RU2013100996A (ru) 2014-07-20
US20170065618A1 (en) 2017-03-09
US10617698B2 (en) 2020-04-14
JP6503445B2 (ja) 2019-04-17
US10688108B2 (en) 2020-06-23
BR112012030653A2 (pt) 2016-08-16
CN102939078A (zh) 2013-02-20
IL247260A0 (en) 2016-09-29
US20150335575A1 (en) 2015-11-26

Similar Documents

Publication Publication Date Title
IL247260A0 (en) A pharmaceutical spray composition containing an analogue of vitamin D and a corticosteroid
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
ZA201301419B (en) Pharmaceutical composition and administrations thereof
IL236358B (en) Medicinal preparations containing hormone replacements and their use
HK1195793A1 (zh) 結合藥物組合物及其用途
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
IL229267A0 (en) A pharmaceutical composition containing dapaglifosine and cyclodextrin
GB2486567B (en) Pharmaceutical formulation
PT2552397T (pt) Composição cosmética e farmacêutica compreendendo 6-fosfato de n-acetil-glucosamina e um composto da família da vitamina a
HK1177695A1 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d-
IL232970A0 (en) Oral spray compounds
EP2618816A4 (en) AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS
EP2762138A4 (en) PHARMACEUTICAL ACTIVE SUBSTANCE (VARIANT) AND COMPOSITIONS BASED ON IT WITH MODULATING ACTIVITY WITH A CORRESPONDING EFFECT
EP2478909A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPHONATE DERIVATIVES AND HIGH-DOSE CHOLECALCIFEROL
HK1177696A1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue
EP2775831A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
EP2560614A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION
EP2685993A4 (en) PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF
EP2666482A4 (en) PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH PARTICLE COMPOSITION
HK1198910A1 (en) Pharmaceutical composition comprising ebastine and fluticasone
SI2538955T1 (sl) Farmacevtska ali nutracevtska formulacija
PT2597084T (pt) Derivado de n-hidroxiformamida e medicamento contendo o mesmo
IL226048A0 (en) A diphenyl sulfate derivative and a pharmaceutical product containing it as an active ingredient
EP2641603A4 (en) PHARMACEUTICAL FORMULATION HAVING NEUROPROTECTIVE ACTIVITY